Pharmacokinetics and Bioequivalence of XC8 10 mg and 40 mg Tablets in Fasted Volunteers

Clinical trial NCT05558462 · COMPLETED

Trial details

NCT number: NCT05558462
Sponsor: Valenta Pharm JSC
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Influenza Respiratory Viral Infection

Start date: 2022-08-22
Primary completion: 2022-11-11
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.